ea0081p34 | Calcium and Bone | ECE2022
Fischler Rebecca
, Lecoq Anne-Lise
, Briot Karine
, Trabado Severine
, Besson Florent
, Bouziotis Jason
, Goujard Cecile
, Salenave Sylvie
, Leboulleux Sophie
, Carreira Emma
, Chabrolle Christine
, Bernard Corvilain
, Chanson Philippe
, Linglart Agnes
, Grimon Gilles
, Kamenicky Peter
Context: In patients with hypoparathyroidism refractory to conventional treatment, recombinant human (rh)PTH(1-84) or rhPTH(1-34) can be used as second-line therapy and effectively control hypocalcaemia. However, whether rhPTH replacement therapy is safe in the long term is unclear. Our objective was to assess bone effects of long-term therapy of chronic hypoparathyroidism with rhPTH(1-34). Methods: We conducted a monocenter retrospective cross-sectional...